Study of GS-0151 in Participants With Rheumatoid Arthritis
Recruiting now · Phase 1 · Has a placebo group
Conditions studied: Rheumatoid Arthritis
In brief
The goal of this clinical study is to learn more about the study drug GS-0151. The study is done to find how safe, well-tolerated the drug is. This will also assess how the drug is absorbed, modified, distributed and cleared from the body (the pharmacokinetics (PK) of the drug), when given multiple times to participants with rheumatoid arthritis (RA). The primary objectives of this study is to assess the safety and tolerability of multiple ascending doses of GS-0151 in participants with RA and to characterize the PK of GS-0151 following multiple doses of GS-0151 in participants with RA.
Key facts
- Study ID
- NCT06902519
- Run by
- Gilead Sciences
- People needed
- 75
- Starts
- 2025-05-14
- Expected to finish
- 2027-03-01
- Last updated by the study team
- 2026-06-09
Who can join
Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Pinnacle Research Group, LLC — Anniston, Alabama, United States (enrolling)
- University of California, San Diego — La Jolla, California, United States (enrolling)
- Stanford University School of Medicine — Palo Alto, California, United States (enrolling)
- Medvin Clinical Research — Tujunga, California, United States (enrolling)
- Medvin Clinical Research — Whittier, California, United States (enrolling)
- Clinical Research of West Florida, Inc — Clearwater, Florida, United States (enrolling)
- Great Lakes Clinical Trials dba Flourish Research Chicago — Chicago, Illinois, United States (enrolling)
- Accurate Clinical Research, Inc — Lake Charles, Louisiana, United States (enrolling)
- Lynn Health Science Institute — Oklahoma City, Oklahoma, United States (enrolling)
- Altoona Center for Clinical Research — Duncansville, Pennsylvania, United States (enrolling)
- Accurate Clinical Management, LLC — Baytown, Texas, United States (enrolling)
- Precision Comprehensive Clinical Research Solutions — Colleyville, Texas, United States (enrolling)
- Accurate Clinical Research, Inc — Houston, Texas, United States (enrolling)
- Precision Comprehensive Clinical Research Solutions — Irving, Texas, United States (enrolling)
- Southwest Rheumatology Research — Mesquite, Texas, United States (enrolling)
- Clinical Trials of Texas LLC, dba Flourish Research — San Antonio, Texas, United States (enrolling)
- DM Clinical Research — Tomball, Texas, United States (enrolling)
- Tidewater Clinical Research, LLC/ Virginia Rheumatology Clinic — Virginia Beach, Virginia, United States (enrolling)
- ARENSIA Exploratory Medicine, LLC — Tbilisi, Georgia (enrolling)
- Universitatsklinikum Koln — Cologne, Germany (enrolling)
- Krakenhaus Porz am Rhein — Cologne, Germany (enrolling)
- Hamburger Rheuma Forschungszentrum II — Hamburg, Germany (enrolling)
- Klinikum der Universitat Munchen — München, Germany (enrolling)
- Republican Clinical Hospital "Timofei Mosneaga," Arensia EM — Chisinau, Moldova (enrolling)
- Clinicmed Daniluk — Bialystok, Poland (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.